<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02139969</url>
  </required_header>
  <id_info>
    <org_study_id>PE1401</org_study_id>
    <nct_id>NCT02139969</nct_id>
  </id_info>
  <brief_title>GreenLight XPS Laser System Retrospective Chart Review</brief_title>
  <official_title>GreenLight XPS Laser System for the Treatment of Benign Prostatic Hyperplasia: Evaluation of Safety, Efficacy, and Quality of Life Through Retrospective Chart Review</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to gain information on the safety, efficacy, and quality of life&#xD;
      in subjects who have had the GreenLight XPS procedure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective chart review conducted at six centers in the United States and&#xD;
      Canada. This review will evaluate the safety and efficacy of GreenLight XPS in subjects who&#xD;
      received treatment on or after 01-Aug-2010.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>International Prostate Symptom Score (IPSS)</measure>
    <time_frame>6 months post-procedure</time_frame>
    <description>Evaluate the proportion of subjects who have mild or no BPH symptoms at six months post-procedure; e.g. an IPSS of eight or less at 6-month follow-up. An IPSS of eight or less indicates the subject is asymptomatic or has mild symptoms, a score of 9-21 indicates the subject has moderate symptoms, and a score of &gt;21 indicates the subject has severe symptoms. IPSS scores can range from 0-35.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of Adverse Events Related to the Study Treatment.</measure>
    <time_frame>365 Days</time_frame>
    <description>Treatment-related adverse events include:&#xD;
Event related to the study device or procedure&#xD;
Intra-operative adverse event related to the study device or procedure&#xD;
Serious adverse events related to the study device or procedure&#xD;
The number of events as well as the number and percentage of subjects with the event will be calculated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characteristics of the Study Procedure</measure>
    <time_frame>Participants will be followed from admission through discharge from the medical facility, an expected average of 2 days.</time_frame>
    <description>Summary of the study procedure, including length of procedure and lasing time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characteristics of the Study Procedure and Immediate Outcomes</measure>
    <time_frame>Participants will be followed from admission through discharge from the medical facility, an expected average of 2 days.</time_frame>
    <description>Summary of characteristics of the study procedure and immediate outcomes: total energy used (kJ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess Changes in Quality of Life Related to BPH Symptoms.</measure>
    <time_frame>Baseline through six months post-procedure</time_frame>
    <description>Summarize IPSS-QOL from baseline through six months post-procedure for all data available during the retrospective review. The quality of life assessment responses includes: Delighted, Pleased, Mostly Satisfied, Mixed-neither satisfied or dissatisfied, Mostly Dissatisfied, Unhappy, or Terrible (range of 0 to 6).The results presented below represent the change from baseline to six months post-procedure for any response. Lower scores indicate a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess Changes in Objective Measures of Urologic Function.</measure>
    <time_frame>Baseline through six months post-procedure.</time_frame>
    <description>Changes in objective measures of urologic function from baseline through six months post-procedure using Peak Flow Rate (Qmax)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With ER Visits, Hospital Admissions, and Surgical Re-treatments for Treatment-related Adverse Events Up to 90 Days Post-Procedure</measure>
    <time_frame>Up to 90 days post-procedure.</time_frame>
    <description>Emergency room visit for an adverse event related to the study device or procedure within 90 days of procedure&#xD;
Hospital admission for an adverse event related to the study device or procedure within 90 days of procedure&#xD;
Surgical intervention for an adverse event related to the study device or procedure within 90 days of procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the Percentage of Participants Experience Ongoing Treatment-related Urinary Incontinence</measure>
    <time_frame>90 days, 180 days</time_frame>
    <description>The percentage (count/n) of subjects with an ongoing urinary incontinence event at 90 and 180 days post-procedure. An incontinence event is considered ongoing if the onset was on or before the specified time point and the event is either unresolved or resolved after that time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the Occurrence of Surgical Retreatment for BPH in GreenLight XPS Patients.</measure>
    <time_frame>Procedure through five years post-procedure.</time_frame>
    <description>Number of surgical re-treatment for BPH as a result of prostate tissue regrowth or insufficient prostatic tissue removal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characteristics of the Study Procedure and Immediate Outcomes</measure>
    <time_frame>Participants will be followed from admission through discharge from the medical facility, an expected average of 2 days.</time_frame>
    <description>Summarize characteristics of the study procedure and immediate outcomes: length of catheterization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>The number of days from admission through discharge from the medical facility will be measured.</time_frame>
    <description>Summarize length of hospital stay (in days) from admission through discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of Hospital Stay</measure>
    <time_frame>Data will be collected during the time of their hospital stay from admission through discharge</time_frame>
    <description>Summarize characteristics of the type of hospital stay (in-patient vs out-patient with an overnight stay)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Stratified by Number of Fibers Used During Procedure</measure>
    <time_frame>Participants will be followed from admission through discharge from the medical facility, an expected average of 2 days.</time_frame>
    <description>Summarize characteristics of the study procedure and immediate outcomes: number of fibers used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess Changes in Objective Measures of Urologic Function</measure>
    <time_frame>Baseline through six months post-procedure</time_frame>
    <description>Changes in objective measures of urologic function from baseline through six months post-procedure using post void residual</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Objective Measures of Urologic Function</measure>
    <time_frame>Baseline through six months post-procedure.</time_frame>
    <description>Changes in objective measures of urologic function from baseline through six months post-procedure using prostate volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess Changes in Objective Measures of Urologic Function.</measure>
    <time_frame>From baseline through six months post-procedure.</time_frame>
    <description>Changes in objective measures of urologic function from baseline through six months post-procedure using prostate specific antigen</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">956</enrollment>
  <condition>Benign Prostatic Hyperplasia</condition>
  <arm_group>
    <arm_group_label>GreenLight XPS Laser System</arm_group_label>
    <description>Treatment of BPH in men using the GreenLight XPS Laser System and the MoXy fiber</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GreenLight XPS Laser System</intervention_name>
    <arm_group_label>GreenLight XPS Laser System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of males who have had the GreenLight XPS procedure with&#xD;
        the MoXy fiber on or after 01-Aug-2010. The cohort will be selected from six pre-selected&#xD;
        urology clinics in the US and one pre-selected urology clinic in Canada.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men who have had a GreenLight XPS procedure with a MoXy Fiber since 01-Aug-2010.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has had prior radiation.&#xD;
&#xD;
          -  Subject has a diagnosis of neurogenic bladder confirmed by urodynamic studies (BOO,&#xD;
             detrusor overactivity (DO), impaired detrusor contractor (IDC))&#xD;
&#xD;
          -  Subject has a neurologic disorder that would impact bladder function (MS, Parkinson,&#xD;
             Spinal Cord Injury) (note: Stroke patients not excluded)&#xD;
&#xD;
          -  Subject has an artificial urinary sphincter&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmood A. Hai, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affiliates Division, Comprehensive Urology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>El Camino Urology Medical Group, Inc.</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georgia Urology</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Affiliates Division, Comprehensive Urology</name>
      <address>
        <city>Westland</city>
        <state>Michigan</state>
        <zip>48186</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Metro Urology</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Urology of Virginia, PLLC</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Montreal Hospital Center</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>May 13, 2014</study_first_submitted>
  <study_first_submitted_qc>May 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2014</study_first_posted>
  <results_first_submitted>June 7, 2016</results_first_submitted>
  <results_first_submitted_qc>October 16, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 9, 2020</results_first_posted>
  <last_update_submitted>October 16, 2020</last_update_submitted>
  <last_update_submitted_qc>October 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Hyperplasia</mesh_term>
    <mesh_term>Hyperplasia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>GreenLight XPS Laser System</title>
          <description>Treatment of men with BPH using the GreenLight XPS Laser System and the MoXy fiber</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="956"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="956"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>GreenLight XPS Laser System</title>
          <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="956"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.6" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="956"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="199"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="757"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>International Prostate Symptom Score (IPSS)</title>
        <description>Evaluate the proportion of subjects who have mild or no BPH symptoms at six months post-procedure; e.g. an IPSS of eight or less at 6-month follow-up. An IPSS of eight or less indicates the subject is asymptomatic or has mild symptoms, a score of 9-21 indicates the subject has moderate symptoms, and a score of &gt;21 indicates the subject has severe symptoms. IPSS scores can range from 0-35.</description>
        <time_frame>6 months post-procedure</time_frame>
        <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>International Prostate Symptom Score (IPSS)</title>
          <description>Evaluate the proportion of subjects who have mild or no BPH symptoms at six months post-procedure; e.g. an IPSS of eight or less at 6-month follow-up. An IPSS of eight or less indicates the subject is asymptomatic or has mild symptoms, a score of 9-21 indicates the subject has moderate symptoms, and a score of &gt;21 indicates the subject has severe symptoms. IPSS scores can range from 0-35.</description>
          <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="572"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Score of &lt;=8</title>
                  <measurement_list>
                    <measurement group_id="O1" value="437"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Score of 9-21</title>
                  <measurement_list>
                    <measurement group_id="O1" value="118"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Score of &gt;21</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of Adverse Events Related to the Study Treatment.</title>
        <description>Treatment-related adverse events include:&#xD;
Event related to the study device or procedure&#xD;
Intra-operative adverse event related to the study device or procedure&#xD;
Serious adverse events related to the study device or procedure&#xD;
The number of events as well as the number and percentage of subjects with the event will be calculated.</description>
        <time_frame>365 Days</time_frame>
        <population>Number of participants with a treatment-related adverse event.</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of Adverse Events Related to the Study Treatment.</title>
          <description>Treatment-related adverse events include:&#xD;
Event related to the study device or procedure&#xD;
Intra-operative adverse event related to the study device or procedure&#xD;
Serious adverse events related to the study device or procedure&#xD;
The number of events as well as the number and percentage of subjects with the event will be calculated.</description>
          <population>Number of participants with a treatment-related adverse event.</population>
          <units>Treatment-related Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="191"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="249"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characteristics of the Study Procedure</title>
        <description>Summary of the study procedure, including length of procedure and lasing time</description>
        <time_frame>Participants will be followed from admission through discharge from the medical facility, an expected average of 2 days.</time_frame>
        <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Characteristics of the Study Procedure</title>
          <description>Summary of the study procedure, including length of procedure and lasing time</description>
          <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Length of Procedure (minutes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="906"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.1" spread="28.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lasing Time (minutes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="952"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.2" spread="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characteristics of the Study Procedure and Immediate Outcomes</title>
        <description>Summary of characteristics of the study procedure and immediate outcomes: total energy used (kJ)</description>
        <time_frame>Participants will be followed from admission through discharge from the medical facility, an expected average of 2 days.</time_frame>
        <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Characteristics of the Study Procedure and Immediate Outcomes</title>
          <description>Summary of characteristics of the study procedure and immediate outcomes: total energy used (kJ)</description>
          <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
          <units>kJ</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="954"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="275.8" spread="180.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assess Changes in Quality of Life Related to BPH Symptoms.</title>
        <description>Summarize IPSS-QOL from baseline through six months post-procedure for all data available during the retrospective review. The quality of life assessment responses includes: Delighted, Pleased, Mostly Satisfied, Mixed-neither satisfied or dissatisfied, Mostly Dissatisfied, Unhappy, or Terrible (range of 0 to 6).The results presented below represent the change from baseline to six months post-procedure for any response. Lower scores indicate a better outcome.</description>
        <time_frame>Baseline through six months post-procedure</time_frame>
        <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Assess Changes in Quality of Life Related to BPH Symptoms.</title>
          <description>Summarize IPSS-QOL from baseline through six months post-procedure for all data available during the retrospective review. The quality of life assessment responses includes: Delighted, Pleased, Mostly Satisfied, Mixed-neither satisfied or dissatisfied, Mostly Dissatisfied, Unhappy, or Terrible (range of 0 to 6).The results presented below represent the change from baseline to six months post-procedure for any response. Lower scores indicate a better outcome.</description>
          <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assess Changes in Objective Measures of Urologic Function.</title>
        <description>Changes in objective measures of urologic function from baseline through six months post-procedure using Peak Flow Rate (Qmax)</description>
        <time_frame>Baseline through six months post-procedure.</time_frame>
        <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Assess Changes in Objective Measures of Urologic Function.</title>
          <description>Changes in objective measures of urologic function from baseline through six months post-procedure using Peak Flow Rate (Qmax)</description>
          <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
          <units>ml/sec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Peak Flow Rate (Qmax) Baseline (ml/sec)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="707"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Qmax 6 months (ml/sec)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="409"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.0" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Qmax Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="354"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.9" spread="10.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With ER Visits, Hospital Admissions, and Surgical Re-treatments for Treatment-related Adverse Events Up to 90 Days Post-Procedure</title>
        <description>Emergency room visit for an adverse event related to the study device or procedure within 90 days of procedure&#xD;
Hospital admission for an adverse event related to the study device or procedure within 90 days of procedure&#xD;
Surgical intervention for an adverse event related to the study device or procedure within 90 days of procedure</description>
        <time_frame>Up to 90 days post-procedure.</time_frame>
        <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported. Results presented are number of subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With ER Visits, Hospital Admissions, and Surgical Re-treatments for Treatment-related Adverse Events Up to 90 Days Post-Procedure</title>
          <description>Emergency room visit for an adverse event related to the study device or procedure within 90 days of procedure&#xD;
Hospital admission for an adverse event related to the study device or procedure within 90 days of procedure&#xD;
Surgical intervention for an adverse event related to the study device or procedure within 90 days of procedure</description>
          <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported. Results presented are number of subjects.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ER Visit 30 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ER Visit 90 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hospital Admission 30 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hospital Admission 90 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Surgical Re-treatment 90 Days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Evaluate the Percentage of Participants Experience Ongoing Treatment-related Urinary Incontinence</title>
        <description>The percentage (count/n) of subjects with an ongoing urinary incontinence event at 90 and 180 days post-procedure. An incontinence event is considered ongoing if the onset was on or before the specified time point and the event is either unresolved or resolved after that time point.</description>
        <time_frame>90 days, 180 days</time_frame>
        <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluate the Percentage of Participants Experience Ongoing Treatment-related Urinary Incontinence</title>
          <description>The percentage (count/n) of subjects with an ongoing urinary incontinence event at 90 and 180 days post-procedure. An incontinence event is considered ongoing if the onset was on or before the specified time point and the event is either unresolved or resolved after that time point.</description>
          <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
          <units>percentage of incontinence events</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Incontinence, Stress 90 Days</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="898"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" lower_limit="0.4" upper_limit="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Incontinence, Urge 90 Days</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="898"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" lower_limit="0.4" upper_limit="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Incontinence, Stress 180 Days</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="850"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" lower_limit="0.6" upper_limit="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Incontinence, Urge 180 Days</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="851"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" lower_limit="0.5" upper_limit="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assess the Occurrence of Surgical Retreatment for BPH in GreenLight XPS Patients.</title>
        <description>Number of surgical re-treatment for BPH as a result of prostate tissue regrowth or insufficient prostatic tissue removal.</description>
        <time_frame>Procedure through five years post-procedure.</time_frame>
        <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Assess the Occurrence of Surgical Retreatment for BPH in GreenLight XPS Patients.</title>
          <description>Number of surgical re-treatment for BPH as a result of prostate tissue regrowth or insufficient prostatic tissue removal.</description>
          <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="955"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Reobstruction due to prostate regrowth</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Insufficient tissue removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characteristics of the Study Procedure and Immediate Outcomes</title>
        <description>Summarize characteristics of the study procedure and immediate outcomes: length of catheterization</description>
        <time_frame>Participants will be followed from admission through discharge from the medical facility, an expected average of 2 days.</time_frame>
        <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Characteristics of the Study Procedure and Immediate Outcomes</title>
          <description>Summarize characteristics of the study procedure and immediate outcomes: length of catheterization</description>
          <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="709"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" lower_limit="0.1" upper_limit="14.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <description>Summarize length of hospital stay (in days) from admission through discharge</description>
        <time_frame>The number of days from admission through discharge from the medical facility will be measured.</time_frame>
        <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay</title>
          <description>Summarize length of hospital stay (in days) from admission through discharge</description>
          <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="817"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" lower_limit="0.1" upper_limit="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Type of Hospital Stay</title>
        <description>Summarize characteristics of the type of hospital stay (in-patient vs out-patient with an overnight stay)</description>
        <time_frame>Data will be collected during the time of their hospital stay from admission through discharge</time_frame>
        <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Type of Hospital Stay</title>
          <description>Summarize characteristics of the type of hospital stay (in-patient vs out-patient with an overnight stay)</description>
          <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="954"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Admission Type: Outpatient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="674"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Admission Type: Outpatient overnight stay</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Admission Type: inpatient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Stratified by Number of Fibers Used During Procedure</title>
        <description>Summarize characteristics of the study procedure and immediate outcomes: number of fibers used</description>
        <time_frame>Participants will be followed from admission through discharge from the medical facility, an expected average of 2 days.</time_frame>
        <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Stratified by Number of Fibers Used During Procedure</title>
          <description>Summarize characteristics of the study procedure and immediate outcomes: number of fibers used</description>
          <population>Data collected for this study was retrospective in nature and only data available in the medical records could be reported.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="953"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of Fibers Used: 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="873"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Fibers Used: 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of Fibers Used: &gt;=3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assess Changes in Objective Measures of Urologic Function</title>
        <description>Changes in objective measures of urologic function from baseline through six months post-procedure using post void residual</description>
        <time_frame>Baseline through six months post-procedure</time_frame>
        <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Assess Changes in Objective Measures of Urologic Function</title>
          <description>Changes in objective measures of urologic function from baseline through six months post-procedure using post void residual</description>
          <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PVR Baseline (ml)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="811"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="204.3" spread="221.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PVR 6 Months (ml)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="583"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.1" spread="95.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PVR Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="511"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-172" spread="215.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Objective Measures of Urologic Function</title>
        <description>Changes in objective measures of urologic function from baseline through six months post-procedure using prostate volume</description>
        <time_frame>Baseline through six months post-procedure.</time_frame>
        <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Objective Measures of Urologic Function</title>
          <description>Changes in objective measures of urologic function from baseline through six months post-procedure using prostate volume</description>
          <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Prostate Volume (g) Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="804"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.0" spread="49.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prostate Volume (g) 6 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="148"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.0" spread="36.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prostate Volume (g) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="141"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-31.8" spread="38.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assess Changes in Objective Measures of Urologic Function.</title>
        <description>Changes in objective measures of urologic function from baseline through six months post-procedure using prostate specific antigen</description>
        <time_frame>From baseline through six months post-procedure.</time_frame>
        <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
        <group_list>
          <group group_id="O1">
            <title>GreenLight XPS Laser System</title>
            <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
          </group>
        </group_list>
        <measure>
          <title>Assess Changes in Objective Measures of Urologic Function.</title>
          <description>Changes in objective measures of urologic function from baseline through six months post-procedure using prostate specific antigen</description>
          <population>This study was retrospective chart review of available data collected in the medical records. The intention was to collect and analyze data through five years post-procedure; however, the data collected was minimal. Results posted here are reflective of the results that have been published (through 6-months).</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="956"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PSA (ng/ml) Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="639"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PSA (ng/ml) 6 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="499"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PSA (ng/ml) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="394"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Any device or treatment related adverse event was collected during the retrospective chart review, up to five years post-procedure for each participant.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>GreenLight XPS Laser System</title>
          <description>Treatment of BPH in men using the GreenLight XPS Laser System</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="956"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="956"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Intraoperative Bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Bladder Neck Obstruction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Hematuria - Gross</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Irritative Voiding Symptoms</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Clot Retention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Reobstruction Due to Prostate Regrowth</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="182" subjects_at_risk="956"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Arrhthmia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="956"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary Incontinence - De Novo Stress</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Urinary Incontinence - De Novo Urge</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="29" subjects_affected="29" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Erectile Dysfunction - De Novo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Bladder Neck Obstruction</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Irritative Voiding Symptoms</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Urinary Frequency</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="39" subjects_affected="39" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Urinary Urgency</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Bladder Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Urethral Injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Urinary Incontinence - Worsening Urge</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Erectile Dysfunction - Worsening</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Bladder Spasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Hematospermia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Hematuria - Gross</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Nocturia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Clot Retention</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Retrograde Ejaculation - De Novo</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Urethral Stricture</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Insufficient Tissue Removal</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Malfunction of XPS Fiber</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Reobstruction Due to Prostate Regrowth</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Excessive Bleeding</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Intraoperative Bleeding</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Perforation - Prostate</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Renal Failure / Insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
              <event>
                <sub_title>Sloughing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="956"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Laura Olson, Clinical Project Manager</name_or_title>
      <organization>Boston Scientific Corporation</organization>
      <phone>9529306428</phone>
      <email>laura.olson2@bsci.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

